3 results
Approved WMOCompleted
To determine the toxicity of adding chloroquine in escalating doses in patients with small cell lung cancer to standard therapy.
Approved WMOCompleted
To determine the toxicity of adding chloroquine in escalating doses in patients with small cell lung cancer to standard therapy.
Approved WMOCompleted
The primary objective is to compare a 12-month antithrombotic regimen of edoxaban in combination with clopidogrel or another P2Y12 antagonist against a regimen of a vitamin K antagonist (VKA) in combination with clopidogrel or another P2Y12…